A pharmaceutical giant approached Freyr for Regulatory assistance with the preparation of Investigator’s Brochure (IB) for multiple novel molecules. The client was looking for assistance in therapeutic areas of oncology, inflammation, and infectious diseases, cardiovascular etc. The major challenge faced by the client was limited availability of source data and strict timelines.

Through this case study, decode how Freyr streamlined the submission process and delivered 15+ IBs under given time.